New combo therapy for tough myeloma cases shows early promise but study halted
NCT ID NCT03031730
First seen Feb 18, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This early-phase study tested a new drug (KRT-232) combined with three standard myeloma treatments in 35 patients whose cancer had come back or stopped responding. The goal was to find the safest dose and check for side effects. The study was terminated early, so results are limited, but the approach aims to control the disease rather than cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah, 84112, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
NYP/Weill Cornell Medical Center
New York, New York, 10065, United States
-
UCHealth University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
-
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
-
University of Texas at Austin
Austin, Texas, 78712, United States
Conditions
Explore the condition pages connected to this study.